Full thickness macular hole and Internal Limiting Membrane (ILM) peeling Study: a randomised comparison of macular hole surgery with or without internal limiting membrane peeling

ISRCTN ISRCTN33175422
DOI https://doi.org/10.1186/ISRCTN33175422
ClinicalTrials.gov (NCT) NCT00286507
Protocol serial number HS028 RGC1462
Sponsor University of Aberdeen (UK)
Funder Chief Scientist Office, Health Department, Scottish Executive (UK)
Submission date
02/08/2005
Registration date
21/09/2005
Last edited
17/08/2018
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Eye Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Noemi Lois
Scientific

Eye Clinic, Foresterhill
Aberdeen
AB25 2ZN
United Kingdom

Phone +44 (0)1224 553217
Email noemilois@aol.com

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Study type Participant information sheet
Scientific titleFull thickness macular hole and Internal Limiting Membrane (ILM) peeling Study: a randomised comparison of macular hole surgery with or without internal limiting membrane peeling
Study acronymFILMS
Study objectivesThe principal research question is whether peeling the internal limiting membrane of the retina improves the vision of patients undergoing macular hole surgery. Secondary questions are whether peeling the internal limiting membrane of the retina improves the anatomical outcome of macular hole surgery and, subsequently, the quality of life of patients with macular holes. Whether internal limiting membrane peeling is cost-effective will also be considered.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedFull-thickness macular holes in the centre of the retina
InterventionParticipants will undergo one of the two possible macular hole surgeries:
1. Surgery without ILM peeling
2. Surgery with ILM peeling
Intervention typeOther
Primary outcome measure(s)

Distance visual acuity at 6 months post surgery.

Key secondary outcome measure(s)

Distance visual acuity at 3 months, near visual acuity at 3 and 6 months, contrast sensitivity at 6 months, reading speed at 6 months, health related quality of life, costs to the health service and the participant, incremental costs per QALY and adverse events.

Completion date31/05/2008

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexAll
Target sample size at registration150
Key inclusion criteriaPatients with idiopathic full-thickness macular holes (FTMHs) stages 2-3 of equal to or less than 18 months duration and with vision equal to or worse than 20/40 in the study eye.
Key exclusion criteriaPatients with macular holes of stage 1 or 4 or with a hole of greater than 18 months duration will be excluded. If the FTMH is related to high myopia or trauma or there are other causes of decreased vision (e.g. corneal scarring, age-related macular degeneration, diabetic retinopathy, glaucoma if central and/or paracentral absolute visual field defects are present) will also be excluded. Patients who are unable to understand English or give informed consent to be excluded.
Date of first enrolment01/06/2005
Date of final enrolment31/05/2008

Locations

Countries of recruitment

  • United Kingdom
  • Scotland

Study participating centre

Eye Clinic, Foresterhill
Aberdeen
AB25 2ZN
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/03/2011 Yes No
Protocol article protocol 03/11/2008 Yes No
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes
Study website Study website 11/11/2025 11/11/2025 No Yes

Editorial Notes

17/08/2018: Publication reference added.